SOLVMay 26, 2026 at 8:27 PM UTCHealth Care Equipment & Services

Unrelated Offering by SOLV Energy Does Not Affect Solventum Thesis

Read source article

What happened

SOLV Energy, a separate company sharing the SOLV ticker, announced a public offering of its Class A common stock, including 14 million shares from the company and selling stockholders. This event has no bearing on Solventum Corp's fundamental outlook. Solventum remains overvalued per the DeepValue report, trading at 73.88 versus a DCF intrinsic value of 25.39, with declining free cash flow and elevated leverage (Net debt/EBITDA 4.75x). The offering does not provide a catalyst for Solventum, as the two entities are distinct.

Implication

Investors should focus on Solventum's own challenges: the stock trades at a 191% premium to intrinsic value, free cash flow has deteriorated from $1.9B in 2021 to $805M in 2024, and net debt/EBITDA remains high at 4.75x. No new catalysts from this news alter the SELL stance. Monitor Solventum's balance sheet de-risking and cash flow recovery as key watch items.

Thesis delta

No change to Solventum thesis. The offering by a different entity using the same ticker does not impact Solventum's overvaluation or financial health. The SELL recommendation remains intact.

Confidence

Low